SHANGHAI and HONG KONG, Dec. 17, 2025 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the Malaysian National Pharmaceutical Regulatory Agency has approved a supplemental New Drug Application (sNDA) for XPOVIO® (selinexor) for the treatment of adult patients with relapsed or refractory diffuse l
KUALA LUMPUR, Malaysia, Dec. 17, 2025 -- Robotware.ai , a Korea-based artificial intelligence company specializing in livestock intelligence solutions, is advancing its proof-of-concept (PoC) deployment in Malaysia in collaboration with Sarawak Digital Economy Corporation (SDEC) , following the successful implementation of its system at local poultry farms. The ongoing PoC is focused on validating the real-world performance of Robotware.ai's AI-powered poultry disease detection technology under live farm operating conditions. The initiative aligns with Malaysia's efforts to moderniz
SINGAPORE, Dec. 17, 2025 -- Instage Technology Pte. Ltd., a subsidiary of SHOPLINE, a leading global commerce Software-as-a-Service (SaaS) platform, today announced that it has obtained the Major Payment Institution (MPI) licence issued by the Monetary Authority of Singapore (MAS). The licence covers five regulated payment services — Account Issuance Service, Domestic Money Transfer Service, Cross-Border Money Transfer Service, Merchant Acquisition Service, and E-Money Issuance Service — enabling SHOPLINE to further strengthen comprehensive payment solutions for over 600,000 merchants
SINGAPORE, Dec. 17, 2025 -- Instage Technology Pte. Ltd., a subsidiary of SHOPLINE, a leading global commerce Software-as-a-Service (SaaS) platform, today announced that it has obtained the Major Payment Institution (MPI) licence issued by the Monetary Authority of Singapore (MAS). The licence covers five regulated payment services — Account Issuance Service, Domestic Money Transfer Service, Cross-Border Money Transfer Service, Merchant Acquisition Service, and E-Money Issuance Service — enabling SHOPLINE to further strengthen comprehensive payment solutions for over 600,000 merchants
BEIJING, Dec. 17, 2025 -- Editor's Note: Perched on the Qinghai-Xizang Plateau, a stone has captivated scholars by reshaping the narrative of early Chinese history. The Garitang Keshi, which can be translated as "Garitang Engraved Stone," has been identified as an authentic relic of the Qin Dynasty (221BC-206BC). It records an imperial mission by Emperor Qinshihuang, who unified China for the first time, to seek the elixir of life from the mythical Kunlun Mountains. Scholars highlight the stone as a geographic anchor that places the legendary "Kunlun" near the sourc
HONG KONG, Dec. 17, 2025 -- ICAC Commissioner Woo Ying-ming, in his capacity of President of the International Association of Anti-Corruption Authorities (IAACA), earlier attended the IAACA Annual Conference held in Doha, Qatar and delivered an opening remarks through video conferencing. Mr Woo was going to head a delegation to Doha to chair the IAACA Executive Committee meeting, attend the IAACA Annual Conference and host bilateral meetings with heads of anti-corruption agencies (ACAs) between December 12 and 14. In light of the fire at Wang Fuk Court in Tai Po, Mr Woo decided
ADELAIDE, Australia, Dec. 17, 2025 -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery. Ferronova's super-paramagnetic iron oxide nanoparticles bind to cells found in lymph nodes which aim to enable identification of tissue that could contain cancerous cells. The technology aims to support more informed surgical decision-making and address the problem that cancer cells are oft
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, Dec. 17, 2025 -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generation multi-specific antibodies. Under the terms of the agreement, Harbour BioMed will collaborate with Bristol Myers Squibb to advance and accelerate multi-specific antibody discovery pro
HONG KONG, Dec. 17, 2025 -- Recently, Meizhou in Guangdong, known as the "World Capital of the Hakka", welcomed a globally watched event, the Seventh World Hakka Entrepreneurs Convention. At this gathering that drew the attention of Hakka entrepreneurs worldwide, Guangdong Jiaying Pharmaceutical Co., Ltd. made a brilliant appearance with its star products, including Double-ingredient Throat Wind Relief Powder, Solid Essence Ginseng and Antler Pill, and Borneol Ointment, showcasing to the world the unique charm of Hakka medicine. Amid the wave of globalization, traditional Chi
ナイロビ(ケニア), 2025年12月17日 -- Montranは、ケニアを拠点とする地域本部Montran Africaを正式に設立し、世界で最もダイナミックな金融エコシステムの一つにおいて、グローバルなフィンテックリーダーとしてのパートナーシップ、近接性、そして成長の新たな時代の幕開けを示しました。 同イベントには、アフリカ各地の中央銀行、金融機関、規制当局、業界リーダーの代表者が出席し、Montranが長年にわたり同大陸と築いてきたパートナーシップと、地域事業の正式な体制構築を称えました。ナイロビを拠点とする本社は、急速に進化するアフリカの金融環境において、顧客との連携、導入支援、イノベーション推進の中核拠点としての役割を担います。 「アフリカでは、世界の金融分野において最も刺激的な変革の一つが進行しています」と、MontranのCEOであるAlexander Esca氏は述べました。「Montran Africaの設立は、アフリカ大陸に対する当社の揺るぎないコミットメントを示すものです。当社は長年にわたりアフリカの金融の歩みの一部であり続けてきましたが、今日、その関係をさらに深化させています。」 Montran Africaの地域統括エグゼクティブディレクターであるWohoro Ndohho氏の指揮の下、新オフィスは顧客とのより